Eric Smouha, MD
Otology & Neurotology · New York, NYNPI 1780644302
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,416 of the $5,187 with a category attached, or 85.1%. It is spread thinly across 27 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 154 payments — averaging $33.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Med-el Corporation$946
- GSK$641
- Sanofi$613
- Cochlear Americas$453
- Kaleo, Inc.$354
- Inspire Medical Systems, Inc.$268
- plus $2K from 21 others
What the payments were for
- Travel & lodging$77115%
- Food & beverage$4,41685%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Med-el Corporation | 8 | $946 |
| GSK | 29 | $641 |
| Sanofi | 24 | $613 |
| Cochlear Americas | 4 | $453 |
| Kaleo, Inc. | 17 | $354 |
| Inspire Medical Systems, Inc. | 8 | $268 |
| Stryker | 4 | $257 |
| Medtronic | 3 | $250 |
| Optinose US, Inc. | 11 | $208 |
| Regeneron Healthcare Solutions, Inc. | 11 | $194 |
| Novartis | 5 | $145 |
| Aerin Medical Inc. | 2 | $107 |
| Integra Lifesciences Corporation | 3 | $90 |
| Alk-abello, Inc | 5 | $89 |
| Intersect ENT, Inc. | 1 | $77 |
| Boehringer Ingelheim | 3 | $73 |
| Neurent Medical Limited | 1 | $69 |
| Smith+Nephew | 3 | $56 |
| Hikma Pharmaceuticals USA | 1 | $51 |
| Amgen | 2 | $50 |
| Acclarent, Inc | 2 | $45 |
| Blueprint Medicines Corporation | 1 | $37 |
| Phadia US Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Octapharma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,187 in reported general payments places this provider in the 65th percentile of 26 otology & neurotology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 48 | $5,473 |
| Ofloxacin | 99 | $5,412 |
| Acetazolamide | 88 | $4,752 |
| Acetic Acid | 18 | $396 |
| Meclizine Hcl | 43 | $266 |
| Betamethasone Dipropionate | 11 | $239 |
| Baclofen | 11 | $198 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 44 | $196 |
| Fluticasone Propionate | 14 | $119 |
| Prednisone | 28 | $107 |
| Hydrochlorothiazide | 22 | $28 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in New York
- John RolandNew York$86K
- Sean McMenomeyNew York$27K
- Daniel JethanamestNew York$17K
- Zachary SchwamNew York$15K
- David FriedmannNew York$11K
- George AlexiadesNew York$8K
- Sujana ChandrasekharNew York$5K
- Darius KohanNew York$3K
- Neil SperlingNew York$2K
- Won Taek ChoeNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.